HELP
HELP
NASDAQ · Pharmaceuticals

Cybin Inc

$11.37
+0.27 (+2.43%)
As of Aug 8, 2:38 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target -14.5% upside
Low Target $6.32
Average Target $9.72
High Target $10.76
Current Price $11.37
Current
$11.37
Target
$9.72
$6.32 $9.72 avg $10.76
Scenario Analysis
Bear Case
$6.32
-44.4%
Low target
Base Case
$9.72
-14.5%
Avg target
Bull Case
$10.76
+-5.4%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$16.10
-29.4% from high
52-Week Low
$5.30
+114.5% from low
Target vs 52W High
$9.72
-39.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%